These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8344489)

  • 1. Gene and chromosomal alterations associated with the development of human gliomas.
    Collins VP; James CD
    FASEB J; 1993 Jul; 7(10):926-30. PubMed ID: 8344489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant glioma].
    Okamura K
    Nihon Rinsho; 1995 Nov; 53(11):2678-83. PubMed ID: 8538025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics and molecular genetics of nervous system tumors.
    Rey JA; Pestaña A; Bello MJ
    Oncol Res; 1992; 4(8-9):321-31. PubMed ID: 1336685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the TP53 gene in human gliomas.
    Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
    Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
    Reifenberger J; Reifenberger G; Liu L; James CD; Wechsler W; Collins VP
    Am J Pathol; 1994 Nov; 145(5):1175-90. PubMed ID: 7977648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N; Jaafart H; Isa MN; Abdullah JM
    Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10.
    Karlbom AE; James CD; Boethius J; Cavenee WK; Collins VP; Nordenskjöld M; Larsson C
    Hum Genet; 1993 Sep; 92(2):169-74. PubMed ID: 8370584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of malignant degeneration of astrocytoma.
    Furnari FB; Huang HJ; Cavenee WK
    Pediatr Neurosurg; 1996; 24(1):41-9. PubMed ID: 8817614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.
    Olopade OI; Jenkins RB; Ransom DT; Malik K; Pomykala H; Nobori T; Cowan JM; Rowley JD; Diaz MO
    Cancer Res; 1992 May; 52(9):2523-9. PubMed ID: 1568221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
    Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA content and chromosomal composition of malignant human gliomas.
    Bigner SH; Bjerkvig R; Laerum OD
    Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations in glioma and medulloblastoma.
    Rasheed BK; Bigner SH
    Cancer Metastasis Rev; 1991 Dec; 10(4):289-99. PubMed ID: 1786630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma.
    Bigner SH; Vogelstein B
    Brain Pathol; 1990 Sep; 1(1):12-8. PubMed ID: 1669688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenes and glial tumors.
    Watkins D; Rouleau GA
    Rev Neurol (Paris); 1992; 148(6-7):402-7. PubMed ID: 1448659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of molecular development of human glioma].
    Schlegel U
    Nervenarzt; 1993 Aug; 64(8):485-93. PubMed ID: 8413746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Towards a molecular classification of gliomas].
    Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
    Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations of the von Hippel-Lindau tumor suppressor gene and loss of heterozygosity on chromosome 3p in human glial tumors.
    Kanno H; Shuin T; Kondo K; Yamamoto I; Ito S; Shinonaga M; Yoshida M; Yao M
    Cancer Res; 1997 Mar; 57(6):1035-8. PubMed ID: 9067265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.